학술논문
P151 - Lenvatinib plus Pembrolizumab as first-line treatment in patients with advanced renal cell carcinoma – real world data from a retrospective multi-center analysis
Document Type
Abstract
Author
Source
In European Urology Open Science November 2023 57 Supplement 1:S219-S220
Subject
Language
ISSN
2666-1683